Israel Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorders, Musculoskeletal, Anti-infective, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast, and Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIsrael Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorders, Musculoskeletal, Anti-infective, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast, and Opportunities, 2028
Pharmaceuticals are a group of organic compounds that can be utilized for diagnosis, treatment, or prevention of a disease and for restoring any organic function. Most of the pharmaceutical products are proteins or polypeptides which can either be obtained naturally or can be extracted from genetically modified microorganisms. Generally, these products are delivered to the patients in the solid form such as tablets or aerosols. Israel pharmaceuticals market is ranked as fourth largest supplier of pharmaceutical products in the world due to its high financial investment in research and development (R&D) of pharmaceutical products and impressive international reach. Rising prevalence of various non-communicable diseases especially cancer, diabetes, and cardiac disorders among people of the country is likely to register an impressive growth to Israel pharmaceuticals Market. Government of Israel is developing its focus on conducting more health education programs along with formation of new health insurance policies every year which is influencing people to take proper care of their health and is thereby progressing the pharmaceuticals market in the country. Moreover, growth in geriatric population of the country and various health problems associated with people in their old age is expected to propel the growth of Israel pharmaceuticals market.
Growing Prevalence of Chronic Diseases
15% of the total number of deaths per year.
Download Free Sample ReportRise in Health Education Programs and Government Initiatives
Government of Israel is taking numerous initiatives to spread the importance of healthcare among people by organizing various healthcare education programs in every region of the country.
Introduction of Health Insurance Policies
Israel has one of the most advanced and highest quality healthcare systems in the world and is ranked at tenth position globally due to its affordable healthcare system. According to the National Health Insurance law every Israeli citizen is entitled to health care services. It makes the purchase of medicines and various other pharmaceutical products more affordable for people which is fueling the growth of Israel pharmaceutical market.
Growth in Geriatric Population
According to the report published by AHA Journal in 2020, around 42% of men and 31% of women who were above 75 years of age, were resulted suffering from severe cardiac illness. Moreover, in Israel, about 25,000 people are hospitalized for myocardial infarction each year. 43,000 patients undergo coronary angiography and 23,000 undergo percutaneous coronary intervention each year. In most cases, the situation is the same as in diagnostic procedures, but about 50% occur during hospitalization for acute coronary syndrome (ACS).3 The ratio of percutaneous coronary intervention to coronary artery bypass surgery is 81 which is one of the highest in the world.
Recent Developments
- Pharmaceuticalgiant Pfizer Pharmaceuticals Israel Ltd. has invested USD 20 million in Israelifirm CytoReason, a developer of computational disease models for drug researchand development, as part of a larger deal worth up to USD 110 million over thenext five years. The agreement builds on anexisting multi-year collaboration agreement signed in 2019, allowing Pfizer toleverage CytoReason's digital models of the human immune system and disease forthe development of innovative medicines.
- Doxil (known asCaelyx in Europe and Canada) is the world's first nanodrug to treat varioustypes of cancer, developed by researchers at the Hebrew University ofJerusalem. The Weizmann Institute of Science has developed Copaxone, abreakthrough drug for the treatment of multiple sclerosis. This is one of thefirst Israeli drugs to get approved by U.S. Food and Drug Administration. Inrecent decades, Israel has become an important part of the globalpharmaceutical industry, with exports to the United States alone rising from USD208 million in 1997 to USD 5.9 billion in 2018.
Market Players
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024-2028 |
| Quantitative Units | Revenue in USD Million, Volume in Tons, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Drug Type Product Type Application Distribution Channel |
| Regional scope | The Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, and The Negev Desert |
| Key companies profiled | Teva Pharmaceutical Industries Ltd, Kamada Pharmaceuticals, MediWound Ltd, Protalix BioTherapeutics Inc, Enlivex Therapeutics Ltd, Bonus BioGroup Ltd, Roche Pharmaceuticals (Israel) Ltd., Rafa Laboratories Ltd. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy